GAPDH and Hyperglycemia: It has been reported that chronic hyperglycemia can lead to an inhibition of pyruvate dehydrogenase (PDH) through mTOR-S6 signaling, which is triggered by glycolytic metabolites upstream of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [23].